Symposium: Redefining Flow Diversion using Pipeline™ Flex with Shield Technology™ — Release of New Clinical Data
Volume 5 Issue 2, pages 38-43
Received – 22nd November 2019, Accepted; 25th November 2019
National Institute of Clinical Neurosciences, Budapest, Hungary.
Paris Sud University, Paris, France.
Qscan Radiology Clinics, Queensland, Australia.
Corresponding Author: Allison Kirsop – email@example.com
Medical writing and editing support was provided by Dr Allison Kirsop, Scientific Writers Ltd, UK and Oruen Ltd, UK.
The symposium was sponsored by Medtronic and took place on Wednesday 4 September 2019 as part of the 12th Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT), Nice, France. Preliminary results within the INSPIRE registry highlight the real-world experience revealing complete occlusion in 70% of cases (N = 114); those aneurysms were not only in the carotid syphon but also in the posterior circulation. There was no significant parent artery stenosis in the majority of patients. Preliminary results were also presented for the Pipeline™ Flex Embolisation Device with Shield Technology™ which support the safety and efficacy of the device. The primary effectiveness endpoint was met in 71.7% of patients with complete aneurysm occlusion and no significant intimal hyperplasia or incident stenosis of >50%, and no retreatment.
Key words: Acute Ischaemic Stroke, Haemorrhagic Stroke, Inspire Registry, Intracranial Aneurysm, Neurovascular, Pipeline Flex™ Embolisation Device With Shield Technology™.